Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Camurati-Engelmann Syndrome × Radiotherapy, Intensity-Modulated × 30 days × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 11 Oropharyngeal Neoplasms 6 Mouth Neoplasms 4 Laryngeal Neoplasms 4 Prostatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Hypopharyngeal Neoplasms 3 Carcinoma 3 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Breast Neoplasms 2 Anus Neoplasms 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1 Sarcoma 1 Recurrence 1 Pancreatic Intraductal Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Lymphoma, Follicular 1 Lymphoid Interstitial Pneumonia 1 Lung Neoplasms 1 Locally Advanced Cervical Adenocarcinoma 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡